Applications of (S)-(-)-1-Tert-Butoxycarbonyl-3-Aminopyrrolidine in Industrial Manufacturing

(S)-(-)-1-Tert-Butoxycarbonyl-3-Aminopyrrolidine serves as a critical chiral intermediate in advanced chemical synthesis pipelines. Our manufacturing practices prioritize regulatory alignment, production consistency, and technical guidance to support large-scale and specialty production in key downstream industries.

1. Active Pharmaceutical Ingredient (API) Synthesis: Piperazine-Based Drugs

Major pharmaceutical companies use this chiral intermediate to construct piperazine frameworks for several targeted therapies, including central nervous system drugs and specific antineoplastic agents. During multi-step synthesis, its defined stereochemistry directly impacts final drug purity and regulatory acceptance, requiring careful process control from raw material charging to API crystallization.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP/NF and Ph. Eur. monograph requirements for process reagents and intermediates
• 21 CFR Part 210/211 (FDA cGMP regulations)
• EDQM CEP (when applied in API registration dossiers)

Typical usage ratio

• Applied at 1.1–1.3 molar equivalents relative to the target core scaffold; exact charge depends on impurity clearance studies during route optimization

Downstream process integration

• Introduced during initial chiral amination of the pyrrolidine ring or during protective group manipulations, prior to major coupling or condensation steps in the API route

Final product types

• Prescription pharmaceutical compounds containing piperazine or pyrrolidine units
• Advanced intermediates for oncology and CNS drug launches
• Regulatory-submitted bulk APIs for global markets

2. Peptide Synthesis: Custom Peptide Libraries for Research & Diagnostics

Contract peptide synthesis and biopharma research platforms use (S)-(-)-1-Tert-Butoxycarbonyl-3-Aminopyrrolidine as a protected amine building block. Its use ensures the generation of highly pure chiral peptides, essential for activity assays, diagnostics, and early-stage therapeutic screening, particularly when non-natural amino acid motifs elevate selectivity and solubility profiles in target studies.

Industry compliance standards

• ISO 13485 for in vitro diagnostic reagent manufacturing
• Synthetic peptide cGMP guidelines for pre-clinical development (ICH Q11)
• Guidance for Industry: Q6B Specifications for Biotechnology Products
• FDA 21 CFR Part 820 (where diagnostic peptides are produced)

Typical usage ratio

• Added as 1 equivalent per protected monomer block; loading efficiency tailored to sequence length, typically maximizing at 0.8–1.2 mmol/g resin for solid-phase synthesis

Downstream process integration

• Deployed as a protected amine during stepwise chain extension on both solid-phase and solution-phase platforms for custom peptide elongation

Final product types

• Custom bioactive peptide libraries
• Non-natural peptide reference standards for assay development
• Diagnostic probe peptides for ELISA, LC-MS, or immunological analysis

3. Chiral Auxiliary for Fine Chemical Synthesis: Agrochemical Actives

Agrochemical manufacturers utilize the chiral auxiliary properties of (S)-(-)-1-Tert-Butoxycarbonyl-3-Aminopyrrolidine to steer stereospecific synthesis routes for selective insecticides and herbicides. Its high enantioselectivity tightens process reproducibility and supports compliance with global safety and traceability standards in regulated plant protection compound manufacturing.

Industry compliance standards

• FAO/WHO Joint Meeting on Pesticide Specifications (JMPS) Guidelines
• ISO 9001-certified agrochemical manufacturing systems
• Regulatory dossier requirements from US EPA and European Food Safety Authority (EFSA, Regulation (EC) No 1107/2009)
• SANCO/3030/99 guidance for active substance technical grade specifications (EU)

Typical usage ratio

• Incorporated at 0.5–2.0 molar equivalents depending on the complexity of the target active; adjusted based on yield and chiral purity targets specified for each product launch

Downstream process integration

• Applied during key asymmetric transformation or as a transient protecting group in multi-stage fine chemical synthesis ahead of final deprotection and formulation

Final product types

• Chiral intermediates for selective fungicides, insecticides, or herbicides
• Active concentrations for plant protection formulations
• Standardized technical actives supplied to formulators

4. Intermediate in Pharmaceutical Research: Enzyme Inhibitor Discovery

Pharmaceutical research divisions rely on this raw material in early discovery programs to build novel pyrrolidine-derivative libraries for enzyme inhibition screening. In these applications, controlled use supports the synthesis of structurally diverse analogs required for in vitro activity optimization and SAR (structure-activity relationship) development, ensuring reliable route scalability for promising candidates.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP) for preclinical compound synthesis
• Institutional laboratory safety procedures and chemical inventory controls (NIH, EU REACH compliance for intermediates)
• PhRMA/EFPIA guidelines for handling research-use only intermediates
• ISO 17025 when quality control testing is required for regulatory submission data

Typical usage ratio

• Charged at 1.0–1.5 equivalents during core scaffold assembly; quantity is tailored based on exploratory yield optimization per library member

Downstream process integration

• Used as a protected chiral amine source in parallel synthesis schemes, typically at the early or mid-stage where analog diversity is introduced for SAR profiling

Final product types

• Small molecule libraries for enzyme inhibition assays
• Advanced research intermediates used in hit-to-lead programs
• Analytical samples for screening under pharmacological assay platforms

5. Building Block for Specialty Fine Chemicals: Optical Brightener Synthesis

Chemical companies engaged in specialty fine chemicals employ (S)-(-)-1-Tert-Butoxycarbonyl-3-Aminopyrrolidine as a stereochemically pure amine source when constructing new optical brighteners, which demand excellent UV absorption properties and batch-to-batch consistency. The stereodefined pyrrolidine scaffold enables precise functionalization in late-stage synthetic schemes for textile, detergent, and polymer use.

Industry compliance standards

• OEKO-TEX 100 (for textile optical brighteners)
• EN 646 safety testing for food contact paper and board solutions
• ISO 9001 process quality management in specialty chemical manufacturing
• REACH Annex VII/VIII requirements for specialty chemical intermediates

Typical usage ratio

• Applied at 0.8–1.4 molar equivalents relative to fluorophore precursors; adjusted based on desired substitution pattern and luminescent performance endpoints

Downstream process integration

• Supplied as a protected amine during nucleophilic substitution or addition reactions, typically before deprotection and final coupling with aromatic chromophore moieties

Final product types

• Textile optical brighteners
• Detergent-grade whitening agents
• Polymer additives for high-value packaging films